First Time Loading...

Oncternal Therapeutics Inc
NASDAQ:ONCT

Watchlist Manager
Oncternal Therapeutics Inc Logo
Oncternal Therapeutics Inc
NASDAQ:ONCT
Watchlist
Price: 8.7 USD 0.46% Market Closed
Updated: May 20, 2024
Financials Section:
Income Statement Balance Sheet Cash Flow Statement

Balance Sheet

29.1m
-21%
Assets
Growth Rates:
1 Year
-50%
3 Years
-74%
5 Years
+29%
7 Years
+54%
10 Years
-2%
6.2m
-7%
Liabilities
Growth Rates:
1 Year
+7%
3 Years
+7%
5 Years
+245%
7 Years
+29%
10 Years
+32%
22.9m
-24%
Equity
Growth Rates:
1 Year
-56%
3 Years
-79%
5 Years
+10%
7 Years
+61%
10 Years
-9%

Balance Sheet Decomposition
Oncternal Therapeutics Inc

29.1m
Assets
6.2m
Liabilities
29.1m
Assets
6.2m
Liabilities
Current Assets 28.5m
Cash & Short-Term Investments 27m
Receivables 717k
Other Current Assets 760k
Non-Current Assets 637k
PP&E 225k
Other Non-Current Assets 412k
Current Liabilities 6.1m
Accounts Payable 1.5m
Accrued Liabilities 4.7m
Non-Current Liabilities 99k
Other Non-Current Liabilities 99k

Balance Sheet
Oncternal Therapeutics Inc

Rotate your device to view
Balance Sheet
Currency: USD
Dec-2014 Dec-2015 Dec-2016 Dec-2017 Dec-2018 Dec-2019 Dec-2020 Dec-2021 Dec-2022 Dec-2023
Assets
Cash & Cash Equivalents
18
14
9
16
28
20
117
91
37
7
Cash Equivalents
18
14
9
16
28
20
117
91
37
7
Short-Term Investments
31
15
13
28
0
0
0
0
27
28
Total Receivables
0
0
0
0
0
0
0
0
0
1
Other Current Assets
1
3
2
2
3
1
1
2
3
1
Total Current Assets
50
32
24
46
31
21
118
93
67
36
PP&E Net
0
0
0
0
0
0
0
0
0
0
PP&E Gross
0
0
0
0
0
0
0
0
0
0
Accumulated Depreciation
4
3
3
3
3
0
0
0
0
0
Intangible Assets
1
0
0
0
0
0
0
0
0
0
Other Long-Term Assets
0
0
0
0
0
1
1
1
1
0
Total Assets
51
N/A
32
-37%
25
-23%
46
+89%
31
-32%
22
-31%
119
+447%
94
-21%
69
-27%
37
-47%
Liabilities
Accounts Payable
1
0
1
3
3
1
1
2
3
1
Accrued Liabilities
0
0
0
0
0
3
3
4
5
4
Short-Term Debt
0
0
0
0
0
0
0
0
0
0
Other Current Liabilities
32
30
3
5
2
4
2
0
0
0
Total Current Liabilities
33
30
5
8
5
7
6
6
8
5
Long-Term Debt
0
0
0
0
0
0
0
0
0
0
Other Liabilities
0
0
0
0
0
0
0
0
0
1
Total Liabilities
33
N/A
30
-8%
5
-85%
8
+74%
5
-35%
7
+42%
6
-20%
6
-7%
8
+40%
7
-13%
Equity
Common Stock
0
0
0
0
0
0
0
0
0
0
Retained Earnings
495
514
531
562
600
66
83
114
158
198
Additional Paid In Capital
513
515
551
600
626
80
196
202
219
228
Other Equity
0
0
0
0
0
0
0
0
0
0
Total Equity
18
N/A
2
-89%
20
+947%
38
+92%
26
-32%
14
-45%
113
+690%
88
-22%
61
-31%
30
-51%
Total Liabilities & Equity
51
N/A
32
-37%
25
-23%
46
+89%
31
-32%
22
-31%
119
+447%
94
-21%
69
-27%
37
-47%
Shares Outstanding
Common Shares Outstanding
14
14
16
22
24
15
49
49
58
3

See Also

Summary
ONCT intrinsic value, competitors valuation, and company profile.
DCF Valuation
ONCT stock valuation using Discount Cash Flow valuation method.
Relative Valuation
ONCT stock valuation using valuation multiples.
Wall Street Estimates
ONCT price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
ONCT stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Join more than 139,100+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.